Change in pattern of relapse in newly diagnosed high-grade glioma following bevacizumab therapy.

2020 Background: Local recurrence (LR) accounts for > 90% at the time of relapse in newly diagnosed high-grade glioma (HGG) following conventional therapy. Use of bevacizumab has shown impressive r...